Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(16):1361-1363; doi:10.1093/jnci/91.16.1361
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 16, 1361-1363, August 18, 1999
© 1999 Oxford University Press

NEWS

DES Research Heats Up Again After Breast Cancer Finding

Mike Miller

Into a conference room literally frozen with doubt from a hyperactive air-conditioning system came a few warming breezes about the future of research, and funding, into cancers caused by the 1950's drug diethylstilbestrol. Participants at a recent 2-day DES meeting noted the potential for stepped-up research efforts — given confirmation of several earlier studies showing that women exposed to DES decades ago may now face an increased risk for breast cancer.

"Based on continued cohort studies, we are now fairly sure that DES women face a 20% to 30% excess risk for breast cancer," said Robert Hoover, M.D., director of the Epidemiology and Biostatistics Program at the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?